🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an Expanded Access Protocol (EAP) of JZP458 in participants w...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04943952
Treatments Being Tested
This phase III trial studies how well blinatumomab works in combination wit...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2019-07-03
Trial ID
NCT03914625
Treatments Being Tested
The purpose of this study is to make Erwinase available to patients with ac...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00590915
Treatments Being Tested
The overall aim of this study is to determine if epigenetic priming with a ...
Status
Active Not Recruiting
Location
Children's Hospital of Central California
Start Date
2017-06-15
Trial ID
NCT03164057
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
The primary objective of this study (TOTXVI) is to compare the clinical ben...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2007-10-29
Trial ID
NCT00549848
The main purpose of this study is to find out how well participants with re...
Status
Completed
Location
Rady Children's Hospital and Health Center
Start Date
2003-11
Trial ID
NCT00186875
Treatments Being Tested
This research study investigates the tolerability of substituting two cycle...
Status
Recruiting
Location
Texas Children's Cancer and Hematology Center
Start Date
2025-10-22
Trial ID
NCT07059975
This is a phase I study using the Erwinia form of asparaginase in place of ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2009-04-13
Trial ID
NCT00928200
This phase II trial studies how well inotuzumab ozogamicin works in treatin...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-06-19
Trial ID
NCT02981628